Göhring, G., Giagounidis, A., Büsche, G., Hofmann, W., Kreipe, H. H., Fenaux, P., . . . Schlegelberger, B. (2011). Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: Implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide. Ferrata Storti Foundation.

Göhring, Gudrun, Aristoteles Giagounidis, Guntram Büsche, Winfried Hofmann, Hans Heinrich Kreipe, Pierre Fenaux, Eva Hellström-Lindberg, e Brigitte Schlegelberger. Cytogenetic Follow-up By Karyotyping and Fluorescence in Situ Hybridization: Implications for Monitoring Patients With Myelodysplastic Syndrome and Deletion 5q Treated With Lenalidomide. Ferrata Storti Foundation, 2011.

Göhring, Gudrun, et al. Cytogenetic Follow-up By Karyotyping and Fluorescence in Situ Hybridization: Implications for Monitoring Patients With Myelodysplastic Syndrome and Deletion 5q Treated With Lenalidomide. Ferrata Storti Foundation, 2011.